% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Batra:180500,
author = {A. Batra and F. Kiefer and S. Andreas and H. Gohlke and M.
Klein and D. Kotz and U. Mons$^*$ and S. Mühlig and M.
Pötschke-Langer and U. W. Preuss and T. Rüther and C.
Rustler and R. Thomasius and S. Ulbricht and K. U. Petersen},
title = {{S}3 {G}uideline '{S}moking and {T}obacco {D}ependence:
{S}creening, {D}iagnosis, and {T}reatment' - {S}hort
{V}ersion.},
journal = {European addiction research},
volume = {28},
number = {5},
issn = {1022-6877},
address = {Basel},
publisher = {Karger},
reportid = {DKFZ-2022-01379},
pages = {382-400},
year = {2022},
note = {2022;28(5):382-400},
abstract = {In addition to the prevention of tobacco consumption, the
establishment and assurance of high-quality treatment for
harmful use and dependence on tobacco products remains an
important health-related task in Germany. Regular updating
of the Association of the Scientific Medical Societies
(AWMF) S3 guideline 'Smoking and Tobacco Dependence:
Screening, Diagnosis, and Treatment' (Tobacco Guideline)
offers a sustainable and reputable source of knowledge on
smoking cessation.Under the auspices of the German Society
for Psychiatry, Psychotherapy, Psychosomatics, and Neurology
(DGPPN) and the German Society for Addiction Research and
Addiction Therapy (DG-Sucht), the Tobacco Guideline was
revised in 2019-2020 by 63 experts, who were involved in the
development process of the text, in 11 working groups. Undue
influence of conflicts of interest on the guideline could be
minimized through careful conflict of interest management.
Delegates from 50 professional societies discussed the 80
guideline recommendations and voted online.In addition to
recommendations for screening and diagnostics, the Tobacco
Guideline takes a positive stance towards the use of
low-threshold counseling and support services. If, due to
the severity of the tobacco-related disorder, brief
counseling, telephone counseling, or internet- or
smartphone-based methods are not sufficiently effective,
individual or group behavioral therapy, possibly in
combination with medication, is indicated. If nicotine
replacement therapy is not effective, varenicline or
bupropion should be offered. Alternative strategies with a
lower level of recommendation are hypnotherapy,
mindfulness-based treatments, or medication with cytisine.
In adolescents and pregnant women, the use of medication
should be limited to well-specified exceptions and nicotine
replacement. The mean agreement with the recommendations
reached a value of $98\%.$ A general overview of the
treatment recommendations of the Tobacco Guideline is
provided by three clinical algorithms.},
keywords = {Clinical practice guideline (Other) / Germany (Other) /
Guideline (Other) / Nicotine (Other) / Smoking cessation
(Other) / Tobacco (Other)},
cin = {M050},
ddc = {150},
cid = {I:(DE-He78)M050-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:35760048},
doi = {10.1159/000525265},
url = {https://inrepo02.dkfz.de/record/180500},
}